Introduction
Cholesterol, triglyceride and the plasma lipoproteins that transport them are normal physiological components of plasma. The lipoproteins in plasma are responsible for redistributing cholesterol and triglyceride between tissues in processes that are fundamental to energy metabolism and cell membrane homeostasis.
Plasma lipoproteins are the vehicles by which cholesterol and triglyceride are transported in plasma. About 70% of plasma cholesterol exists as cholesteryl esters. Both cholesteryl esters and triglycerides are insoluble in water and they are solubilised by their inclusion into lipid-protein complexes known as lipoproteins. Plasma total cholesterol is distributed among three major lipoprotein classes: very low-density lipoproteins (VLDL), low-density lipoproteins (LDL) and high-density lipoproteins (HDL). Smaller amounts of cholesterol are also contained into minor lipoprotein classes: intermediate density lipoproteins (IDL) and lipoprotein (a) [Lp(a)]. which suggest that insulin resistance, working through hyperinsulinemia, enhances hepatic VLDL synthesis and contributes to the elevated plasma triglyceride levels observed in normalweight healthy subjects, obese non-diabetic subjects and type 2 diabetic subjects 8 .
Most of the studies on insulin resistance were performed on diabetic population. The studies on which non-diabetic people were involved were also performed on obese or overweight subjects. So the prevalence of insulin resistance in the most common metabolic disorders is still an undefined issue.
A study was done in Bruneck, Italy in which the prevalence of insulin resistance in subjects with impaired glucose tolerance (IGT), type 2 diabetes (T2DM), dyslipidemia, hyperuricemia and hypertension were assessed. The results showed prevalence of insulin resistance as 65.9% in IGT subjects, 83.9% in T2DM subjects, 53.5% in hypercholesterolemic subjects, 84.2% in hypertryglyceridemia subjects, 88.1% in subjects with low HDL-cholesterol, 62.8% in hyperuricemia subjects and 58.0% in hypertensive subjects. However, in isolated hypercholesterolemia, hypertension and hyperuricemia, prevalence rates of insulin resistance were not higher than that in non-obese normal subjects. The results suggest that in hypertriglyceridemia and a low HDL cholesterol state, insulin resistance is as common as in T2DM whereas it is less frequent in hypercholesterolemia, hyperuricemia, and hypertension 9 . Average BMI of subjects of that study was 28.0±0.5 kg/m 2 .
Endogenous hypertriglyceridemia has been shown to be associated with insulin resistance and impairment in glucose tolerance 10-11. Moro et al found a very significant correlation between insulin sensitivity and TG levels, this association is also present at normal plasma TG levels 12 . Some Japanese studies reported that high concentration of TG and low HDL-C characterizes Japanese type 2 diabetic patients with insulin resistance [13] [14] [15] .
Hyperlipidemia and dyslipidemia: definition and classification
Abnormalities in plasma lipoprotein transport are expressed as either hyperlipidemia or dyslipidemia. The term hyperlipidemia refers to an increase in concentration of one or more plasma or serum lipids, usually cholesterol and triglycerides and the term dyslipidemia is used for either an increase or decrease in concentration of one or more plasma or serum lipids. The relevance of both in atherosclerosis is illustrated by increasing evidence that deficiency of HDL may be as important a risk factor for coronary heart disease as is an excess of LDL 4 . Hyperlipidemia can be classified based on therapeutic considerations as follows: The desirable lipid profile is as follows: Total cholesterol <5.2 mmol/L, LDL <2.6 mmol/L, HDL 1.15 mmol/L, and triglyceride <1.71 mmol/L. A subject is considered dyslipidemic when one of the above values is affected 1, 6 .
Interaction between insulin sensitivity and hyperlipidemia
Derangements in lipid metabolism is a driving force in the pathogenesis of insulin resistance (IR) 7 . The characteristic lipid profile in an individual with insulin resistance includes: (1) decreased serum HDL cholesterol; (2) increased serum VLDL; and (3) less commonly, an increase in LDL cholestero l8 . The plasma VLDL concentration is determined by two factors: (1) the rate of VLDL synthesis by the liver; and (2) the rate of VLDL removal by peripheral tissues. The former, in turn, is regulated by the ambient plasma insulin concentration and substrate availability. There is much evidence diet, subjects of all groups were consuming ordinary Finish diet. In addition, all had total cholesterol levels lower than 6.5 mmol/L, which indicate moderate cholesterol and fat intake. Thus it is unlikely that environmental factors could explain the insulin resistance observed in the patients with low HDL cholesterol.
In a large study (3568 subjects) in Singapore, they found isolated low HDL cholesterol could cause insulin resistance only in presence of fasting hypertriglyceridemia 21 . In that study they identified subjects with low HDL cholesterol (<0.9 mmol/L) but having ideal total cholesterol (<5.2 mmol/L). Their findings showed insulin resistance in subjects having fasting triglyceride level>1.71 mmol/L, but there was no insulin resistance in subjects having fasting triglyceride level <1.71 mmol/L. However, the subjects of that study were heterogeneous in terms of BMI, blood pressure and other determinants of insulin resistance.
A study performed by Orchard et al 22 showed that the higher the insulin or glucose concentration the higher the atherogenic lipids, total cholesterol, LDL-cholesterol and triglycerides and the lower the protective lipoprotein (HDL-cholesterol).
There are some studies performed on a group of Malaysian Malay subjects who were free from T2DM, obesity, hypertension, IGT and IFG (i.e. free from all risk factors of IR) 23 . In those studies out of 246 subjects 118 were hyperlipidemic, of them 64 were with hypercholesterolemia, and 42 were with mixed hyperlipidaemia and 12 were with isolated hypertriglyceridemia. Fasting insulin level was high and insulin sensitivity was compromised in all three types of hyperlipidemia. Median fasting insulin level of subjects with isolated hypercholesterolemia was 64 pmol/L, which was 78 ρmol/L in subjects with mixed hyperlipidemia and 109 pmol/L in subjects with isolated hypertriglyceridemia which was 34 pmol/L in normolipidemic subjects. The median HOMA%S of subjects in these three groups was
There are several studies which show that insulin resistance is also related with low HDL cholesterol and high triglyceride 16, 17 . Triglyceride concentrations were negatively and HDL were positively correlated to insulin mediated glucose disposal; however their study subjects were obese or overweight. Sum et al studied the relationship between hyperinsulinemia and lipids in non-obese subjects 18 . They found that both basal and post glucose challenge insulin levels are higher in non-obese but hyperlipidemic subjects. Similar report was noted by Laws et al 19 .
There is a study on Finish population in which the degree of insulin resistance and some events of intracellular metabolism of glucose were measured in three groups of subjects with normal glucose tolerance: 1) subjects with isolated low HDL cholesterol (n=12), 2) subjects with low HDL cholesterol and high total triglyceride levels (n=10) and 3) control subjects with normolipidemia (n=17). The results showed that the subjects with low HDL levels are insulin resistant independently of triglyceride levels. In these subjects the rates of whole body glucose uptake was attributable to the decrease in glucose non-oxidation (glycogen synthesis, lipid synthesis and anaerobic glycolysis) and glucose oxidation 20 . The subjects of that study had an average BMI of more than 27 kg/m 2 .
The variation in HDL levels is determined by both environmental and genetic factors. Environmental factors such as obesity especially abdominal obesity, and smoking and sedentary lifestyle influence HDL level. In that study the groups with low HDL levels were more insulin resistant than the control group, even after the exclusion of smokers. Hence insulin resistance in the patient groups could not be explained on the basis of smoking alone. BMI and waist-hip ratio, an indicator of intra abdominal obesity, did not differ between the patients and control subjects, which exclude the possibility that obesity or its distribution could have confounding effects on the results. In respect to 73, 57 and 45, respectively which was as high as 165 in normolipdemic subjects. The mean HOMA-IR of these three groups was 2.25, 3.16 and 4.59 respectively which was only 1.06 in normolipidemic Malay subjects. In all types of hyperlipidemia, there was lowering of insulin sensitivity [24] [25] [26] [27] . The study reports showed that any derangement in blood lipids causes IR. That finding was very important because they used a population which was free from all risk factors of IR.
It is obvious from the above discussion that insulin and lipids have a close relationship and abnormality of one is followed by abnormality of the other. The issue is that which one follows whom? Whether dyslipidemia starts first which causes IR or insulin resistance starts first and gives rise to derangements in blood lipids. What was the cause behind this correlation?
There are two hypotheses answering this question. It is possible that plasma triglyceride-rich lipoproteins may influence early steps in the insulin action pathway such as insulin binding or early post binding intracellular events consequent on insulin binding. As impairment of insulin action has been reported after an infusion of intralipid. In another hypothesis it is possible that insulin resistance may cause increased triglyceride concentrations. The main triglyceride bearing lipoprotein, VLDL, is primarily produced in the liver and is metabolized in plasma in a delipidation cascade catalyzed by lipoprotein lipase. Interaction of insulin resistance with triglyceride metabolism could be either with lipoprotein lipase activity or with VLDL secretion 15 . Bidhan et al 28 and Schmidt et al 29 commented that the lipid pattern of high TG and low HDL-C is a feature of inflammation and they argued that it is due to this and related inflammatory cytokines the insulin resistance results.
Further studies in people with different lipid derangements and insulin resistance are needed with study at molecular level to establish 'cause and effect' relationship between IR and lipid disorders.
